Protocols | PTSD(n = 57) | non-PTSD(n = 161) | ||||
---|---|---|---|---|---|---|
TT(n = 28) | CT(n = 19) | CC(n = 10) | TT(n = 75) | CT(n = 66) | CC(n = 20) | |
Genotype frequency | 49.1% | 33.3% | 17.6% | 46.6% | 41.0% | 12.4% |
Gender (F/M) | 17/11 | 14/5 | 9/1 | 32/43 | 31/35 | 8/12 |
Age, y | 59.25 ± 4.41 | 56.58 ± 6.10 | 54.8 ± 5.06 | 59.59 ± 5.43 | 58.41 ± 5.48 | 57.1 ± 5.27 |
Education, y | 6.54 ± 3.77 | 6.16 ± 4.51 | 6.6 ± 4.41 | 6.28 ± 3.44 | 6.91 ± 3.54 | 7.65 ± 3.73 |
Duration since trauma, m | 58.39 ± 42.84 | 68.84 ± 57.45 | 32.6 ± 29.43 | 111.52 ± 71.67 | 110.59 ± 74.53 | 87.5 ± 55.36 |
CAPS_total | 47 ± 13.29 | 46.32 ± 12.26 | 52 ± 10.91 | 15.89 ± 9.77 | 16.38 ± 10.96 | 16.25 ± 6.92 |
HAMD | 14.89 ± 6.43 | 15.58 ± 6.21 | 19.5 ± 6.31 | 5.62 ± 3.86 | 6.23 ± 4.61 | 5.53 ± 4.08 |
HAMA | 13.07 ± 8.06 | 11.84 ± 4.96 | 13 ± 2.79 | 4.73 ± 3.45 | 4.66 ± 3.6 | 3.68 ± 2.58 |